Recommendation of the President – measurement of fibroblast growth factor FGF-23
On 19 December 2025, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 203/2025 on the assessment of the legitimacy of classifying the measurement of fibroblast growth factor FGF-23 concentration as a guaranteed service in the field of outpatient specialist care